Kevin Keane

ESTP Congress
,

Dr. Kevin Keane is the Senior Director of Pathology at Blueprint Medicines, a Sanofi Company, located in Cambridge, Massachusetts, USA since 2021.  He has also been on the editorial team of the ESTP's official journal for more than 10 years and has been its editor-in-chief since 2020.  In both of these roles, Dr. Keane is deeply committed to expanding and growing the professional standards and techniques that define the practice of toxicologic pathology.  Previous to his current roles, Dr. Keane has worked for several other pharmaceutical companies in New Jersey, Seattle area, China, and Denmark.